NATIXIS ADVISORS, L.P. - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 176 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NATIXIS ADVISORS, L.P. ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$1,215
+163.0%
54,359
+152.9%
0.00%
+300.0%
Q2 2023$462
-100.0%
21,494
-76.2%
0.00%
-91.7%
Q3 2020$1,878,000
+26.1%
90,189
+6.0%
0.01%
+20.0%
Q2 2020$1,489,000
+22.7%
85,089
+14.5%
0.01%0.0%
Q1 2020$1,214,00074,3380.01%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
Rubric Capital Management LP 2,606,500$51,452,0001.44%
Camber Capital Management LP 2,000,000$39,480,0001.22%
Eventide Asset Management 2,629,593$51,908,0000.68%
GREAT POINT PARTNERS LLC 121,342$2,395,0000.56%
RICE HALL JAMES & ASSOCIATES, LLC 753,038$14,865,0000.55%
Values First Advisors, Inc. 41,773$825,0000.53%
CLARK ESTATES INC/NY 183,800$3,628,0000.52%
EMERALD MUTUAL FUND ADVISERS TRUST 710,398$14,023,0000.48%
EMERALD ADVISERS, LLC 590,256$11,652,0000.42%
ACORN FINANCIAL ADVISORY SERVICES INC /ADV 68,812$1,358,0000.42%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders